BOUT:NYE-Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 32.5125

Change

+1.02 (+3.23)%

Market Cap

USD 0.01B

Volume

2.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+0.83 (+0.74%)

USD 15.82B
VOT Vanguard Mid-Cap Growth Index ..

+1.30 (+0.56%)

USD 14.48B
IJK iShares S&P Mid-Cap 400 Growth..

+0.68 (+0.86%)

USD 7.96B
XMMO Invesco S&P MidCap Momentum ET..

+0.51 (+0.47%)

USD 3.25B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+0.56 (+0.57%)

USD 1.01B
ETHO Amplify ETF Trust

+0.43 (+0.86%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

+0.57 (+0.92%)

USD 0.17B
BFOR Barron's 400 ETF

+0.45 (+0.69%)

USD 0.14B
IPO Renaissance IPO ETF

+0.29 (+0.81%)

USD 0.13B
PEXL Pacer US Export Leaders ETF

+0.24 (+0.58%)

USD 0.04B

ETFs Containing BOUT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.78% 6% D- 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.78% 6% D- 17% F
Trailing 12 Months  
Capital Gain -6.27% 56% F 35% F
Dividend Return 0.02% 8% B- N/A F
Total Return -6.26% 56% F 29% F
Trailing 5 Years  
Capital Gain 70.94% 50% F 68% D+
Dividend Return 4.42% 44% F 8% B-
Total Return 75.36% 50% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 11.02% 72% C 69% C-
Dividend Return 11.63% 72% C 65% D
Total Return 0.61% 50% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 22.06% 61% D- 47% F
Risk Adjusted Return 52.71% 72% C 66% D+
Market Capitalization 0.01B 8% B- 8% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.